COXFA4L2 and cancer: Our findings established that not only was NDUFA4L2 significantly overexpressed in HCC (as noted in [27]), but its overexpression follows a significant monotonic pattern across cancer stages, a much stronger statement that would support the role of NDUFA4L2 in driving HCC progression.